surmount-1 tirzepatide weight loss percent 72 weeks for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity First head-to-head trial compares tirzepatide

The probabilistic sensitivity analysis suggested that subcutaneous tirzepatide was most likely to remain cost-effective, with a 98% probability at a willingness to pay of $150,000 per QALY compared with other medications

Always use a new syringe and needle for each injection to prevent infections and blocked needles

Additionally, we will evaluate maintenance of at least 15% body weight reduction for participants who lost at least 15% body weight at the end of the weightloss period

The active ingredient in weight-loss drugs such as Wegovy and Zepbound is either semaglutide or tirzepatide, and both are on the list

Flick the syringe gently with your finger to move bubbles to the top (near the needle), then push the plunger slightly to expel them